Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 6
Submit an article Journal homepage
203
Views
9
CrossRef citations to date
0
Altmetric
Letters to the Editor

Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström’s macroglobulinemia

Maria GavriatopoulouDepartment of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece;
,
Efstathios KastritisDepartment of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece; Correspondence[email protected]
,
Marie-Christine KyrtsonisLaikon Hospital, National and Kapodistrian University of Athens, Athens, Greece;
,
Theodoros P. VassilakopoulosLaikon Hospital, National and Kapodistrian University of Athens, Athens, Greece;
,
Maria RoussouDepartment of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece;
,
Despoina FotiouDepartment of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece;
,
Magdalini MigkouDepartment of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece;
,
Maria MpakiriEvaggelismos General Hospital, Athens, Greece
,
Anna TasidouEvaggelismos General Hospital, Athens, Greece
,
Evangelos TerposDepartment of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece;
&
Meletios Athanasios DimopoulosDepartment of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece;
show all
Pages 1506-1508 | Received 05 Aug 2016, Accepted 29 Aug 2016, Published online: 10 Oct 2016

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Karima Amaador, Marie J. Kersten, Monique C. Minnema & Josephine M. I. Vos. (2023) Treatment of relapsed and refractory Waldenstrom Macroglobulinemia. Leukemia & Lymphoma 64:1, pages 30-41.
Read now
Fotiou Despina, Dimopoulos Meletios Athanasios & Kastritis Efstathios. (2020) Emerging drugs for the treatment of Waldenström macroglobulinemia. Expert Opinion on Emerging Drugs 25:4, pages 433-444.
Read now
Iuliana Vaxman & Morie Gertz. (2020) Waldenstrom's macroglobulinemia in the era of immunotherapy. Leukemia & Lymphoma 61:6, pages 1292-1304.
Read now
Yan-Hua Zheng, Li Xu, Chun Cao, Juan Feng, Hai-Long Tang, Mi-Mi Shu, Guang-Xun Gao & Xie-Qun Chen. (2019) Rituximab-based combination therapy in patients with Waldenström macroglobulinemia: a systematic review and meta-analysis. OncoTargets and Therapy 12, pages 2751-2766.
Read now

Articles from other publishers (5)

Zdeněk Adam, David Zeman, Luděk Pour, Marta Krejčí, Martin Krejčí, Zdeněk Řehák, Renata Koukalová, Viera Sandecká, Martin Štork, Gabriela Romanová, Zuzana Adamová & Zdeněk Král. (2022) Waldenström´s macroglobulinemia, overview of clinical symptoms, and therapy and our experience with ibrutinib therapy. Onkologie 16:Suppl. B, pages 83-102.
Crossref
Despina Fotiou, Foteini Theodorakakou & Efstathios Kastritis. (2022) Monoclonal antibody-based therapies for Waldenström's macroglobulinemia. Leukemia Research Reports 17, pages 100324.
Crossref
Shayna Sarosiek, Steven P. Treon & Jorge J. Castillo. (2021) How to Sequence Therapies in Waldenström Macroglobulinemia. Current Treatment Options in Oncology 22:10.
Crossref
Meletios A. Dimopoulos & Efstathios Kastritis. (2019) How I treat Waldenström macroglobulinemia. Blood 134:23, pages 2022-2035.
Crossref
Andres Dominguez, Efstathios Kastritis & Jorge J. Castillo. (2018) Monoclonal Antibodies for Waldenström Macroglobulinemia. Hematology/Oncology Clinics of North America 32:5, pages 841-852.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.